SEC Filings - Aerovate Therapeutics, Inc.

Filing date	Form	Description	View
June 29, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001104659-21-087033.pdf 0001104659-21-087033.rtf 0001104659-21-087033.xls View HTML
June 29, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001104659-21-087034.pdf 0001104659-21-087034.rtf 0001104659-21-087034.xls View HTML
July 19, 2021	3	Initial filing by director officer or owner of more than ten percent.	0001104659-21-093474.pdf 0001104659-21-093474.rtf 0001104659-21-093474.xls View HTML
March 23, 2022	3	Initial filing by director officer or owner of more than ten percent.	0001493152-22-007497.pdf 0001493152-22-007497.rtf 0001493152-22-007497.xls View HTML
January 23, 2023	3	Initial filing by director officer or owner of more than ten percent.	0001415889-23-001333.pdf 0001415889-23-001333.rtf 0001415889-23-001333.xls View HTML
March 8, 2023	3	Initial filing by director officer or owner of more than ten percent.	0001415889-23-004515.pdf 0001415889-23-004515.rtf 0001415889-23-004515.xls View HTML
July 11, 2023	3	Initial filing by director officer or owner of more than ten percent.	0001415889-23-011008.pdf 0001415889-23-011008.rtf 0001415889-23-011008.xls View HTML
April 29, 2022	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001493152-22-011599.pdf 0001493152-22-011599.rtf 0001493152-22-011599.xls View HTML
April 19, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001798749-23-000028.pdf 0001798749-23-000028.rtf 0001798749-23-000028.xls View HTML
August 16, 2021	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001104659-21-105674.pdf 0001104659-21-105674.rtf 0001104659-21-105674.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.